Categories AlphaGraphs, Earnings, Health Care
JNJ Earnings: All you need to know about Johnson & Johnson’s Q4 2024 earnings results
Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2024 earnings results today.
Reported sales increased 5.3% year-over-year to $22.5 billion. Operational sales growth was 6.7%.
Net earnings decreased 17% to $3.4 billion, or $1.41 per share, compared to last year. Adjusted EPS decreased 10.9% to $2.04.
Revenue surpassed projections while earnings came in line with estimates.
For full-year 2025, the company expects reported sales of $89.2-90.0 billion and adjusted EPS of $10.50-10.70.
The stock stayed red in premarket hours on Wednesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key takeaways from Kroger’s (KR) Q1 2025 earnings report
The Kroger Co. (NYSE: KR) recently reported mixed results for the first quarter of fiscal 2025, with earnings beating estimates and sales missing. The grocery giant’s stock rose following the
What to expect when McCormick & Company (MKC) reports Q2 2025 earnings results
Shares of McCormick & Company, Incorporated (NYSE: MKC) gained over 1% on Monday. The stock has dropped 7% over the past three months. The condiments maker is slated to report its second
Earnings Preview: Paychex (PAYX) looks set to end FY25 on a strong note
Paychex Inc. (NASDAQ: PAYX) has benefited from the stable labor market and resilient customers, despite inflationary pressures and the challenging economic environment. The company is leveraging its strong fundamentals and
